Skip to content
Clinical Trials – home
The NetherlandsBack to the Netherlands

Clinical trials in Amsterdam – page 65

1 084 clinical trials in Amsterdam, The Netherlands across 14 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

The NetherlandsOur site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)
Amsterdam at a glance
1 084
clinical trials
  • Research sites14
Type of trial
Recruitment status
Quick filters

1 084 trials in Amsterdam

Open in trial search

Oesophageal carcinoma

Not recruiting

Study of Nivolumab for Patients with Esophageal Cancer Undergoing Active Surveillance After Chemoradiation

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

EGFR gene mutation+1

Not recruiting

Study on the Effectiveness and Safety of BAY 2927088 Compared to Standard Treatment in Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Bay 2927088
  • Sponsor:Bayer AG

Neoplasm malignant+1

Not recruiting

Study of ACP-017 and Pembrolizumab for Patients with Advanced or Metastatic Cancer

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Acp-017
  • Sponsor:Ascendis Pharma Oncology Division A/S

Study on the Effects of Ertugliflozin and Sodium Intake on Blood Pressure in Overweight Adults with Type 2 Diabetes

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:65+ years
  • Substances:Ertugliflozin
  • Sponsor:Amsterdam UMC Stichting

EGFR gene mutation+1

Not recruiting

Study on Amivantamab, Lazertinib, and Bevacizumab for Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer After Treatment Progression

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Amivantamab
  • Sponsor:ETOP IBCSG Partners Foundation

Study on the Safety and Effects of PDC*lung01 Vaccine with Pemetrexed or Pembrolizumab for Patients with Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:PDC line pharma

Desmoid tumour

Not recruiting

Study of varegacestat (AL102) in patients with progressing desmoid tumors

Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Varegacestat
  • Sponsor:Immunome Inc.
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Bleomycin Sulfate
  • Sponsor:University Of Cologne

Neuropathic arthropathy+1

Not recruiting

Study on Denosumab for Healing Bone Fractures in Diabetic Patients with Charcot Foot

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Denosumab
  • Sponsor:Amsterdam UMC Stichting

Crohn's disease

Not recruiting

Study on the Safety and Effectiveness of AZD7798 for Adults with Ileal Crohn's Disease and an Ileostomy

Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Azd7798
  • Sponsor:AstraZeneca AB

Hereditary angioedema

Not recruiting

Study on the Safety of Donidalorsen for Patients with Hereditary Angioedema

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:Donidalorsen
  • Sponsor:Ionis Pharmaceuticals Inc.

Renal transplant

Not recruiting

Study of tacrolimus, everolimus and mycophenolate mofetil combination in elderly patients after kidney transplant

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:65+ years
  • Substances:Basiliximab
  • Sponsor:Universitair Medisch Centrum Groningen

Other cities in the Netherlands

The busiest research cities in the country

All 103 cities in the Netherlands

Clinical research in Amsterdam

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on colorectal cancer, bladder cancer, and gastric cancer treatments. Studies include novel combination therapies and immunological approaches to improve patient outcomes.

  • Advanced cancer treatments
  • Immunotherapy studies
  • Diagnostic imaging innovations

Research includes evaluation of new drug combinations and targeted therapies for various cancer types.

02 Neurological Studies

Groundbreaking research into Alzheimer's Disease and inflammatory polyneuropathy, focusing on early detection and treatment effectiveness. Studies include innovative biomarker research and twin-based investigations.

  • Preclinical Alzheimer's research
  • Neurological disorders
  • Biomarker studies

Emphasis on understanding disease progression and developing new therapeutic approaches.

03 Immunology and Infectious Diseases

Studies examining HPV prevention, mpox vaccination, and various immune-related conditions. Research includes vaccine effectiveness and novel treatment approaches for chronic conditions.

  • Vaccine studies
  • Viral infections
  • Immune system responses

Focus on preventive measures and treatment optimization for infectious diseases.

04 Specialized Therapeutics

Research involving eye conditions, dermatological treatments, and gastrointestinal disorders. Studies range from prosthetic eye care to innovative treatments for chronic conditions.

  • Ophthalmological care
  • Dermatology treatments
  • Digestive disorders

Investigating new therapeutic approaches for various specialized medical conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.